Drug recall · March 25, 2026
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%* recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp. Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1.
- Lots / codes
Lots VJ8599, Exp Date 09/30/2026 & VL1668, Exp Date 01/31/2027
- Quantity
- 107,136 vials
- Company
- Apotex Corp., Weston, FL
- Distribution
- U.S. Nationwide
- Initiated
- March 5, 2026 · Voluntary: Firm initiated
- Classified
- March 27, 2026
- Reported
- March 25, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Brimonidine / timolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.